4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-17-037516
EVP, Chief Financial Officer acquired 8,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bell Graeme · EVP, Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-02 | Grant or award : show line 1 in the form | +8,400 | $12.37 | $103,938 | 8,400 | D |
Loading xslF345X03/doc4.xml…